| Schedule of Net Income (Loss) Attribute To Common Stockholders |
The following table summarizes net loss attributable to common stockholders and participating securities used in the calculation of basic and diluted loss per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | (In thousands, except share and per share data) | 2025 | | 2024 | | 2025 | | 2024 | | Basic loss per share: | | | | | | | | | Net loss attributable to common stock and participating securities used to calculate basic loss per share | $ | (82,381) | | | $ | (19,824) | | | $ | (116,503) | | | $ | (90,040) | | | Weighted average common shares outstanding | 3,735,472 | | 471,317 | | 3,692,593 | | | 470,611 | | Dilutive effect of pre-funded warrants | 10,012 | | 10,012 | | 10,012 | | | 10,012 | | Weighted average shares outstanding for EPS | 3,745,484 | | 481,329 | | 3,702,605 | | | 480,623 | | Basic loss per share | $ | (21.99) | | | $ | (41.19) | | | $ | (31.47) | | | $ | (187.34) | | | | | | | | | | | Diluted loss per share: | | | | | | | | | Net loss attributable to common stock and participating securities used to calculate diluted loss per share | $ | (82,381) | | | $ | (19,824) | | | $ | (116,503) | | | $ | (90,040) | | | Weighted average common shares outstanding | 3,735,472 | | 471,317 | | 3,692,593 | | | 470,611 | | Weighted average pre-funded warrants | 10,012 | | 10,012 | | 10,012 | | | 10,012 | | Weighted average shares outstanding for EPS | 3,745,484 | | 481,329 | | 3,702,605 | | | 480,623 | | Diluted loss per share | $ | (21.99) | | | $ | (41.19) | | | $ | (31.47) | | | $ | (187.34) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following common stock equivalent shares were excluded from the calculation of diluted loss per share since their impact would have been anti-dilutive for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Shares underlying warrants | 339,807 | | | 66,667 | | | 339,807 | | | 66,667 | | | Stock options | 52,455 | | | 7,759 | | | 52,455 | | | 7,759 | | | Restricted stock units | 432 | | | 4,514 | | | 432 | | | 4,514 | | | Shares issuable under the Employee Stock Purchase Plan | 28,839 | | | 1,788 | | | 28,839 | | | 1,788 | | | Share equivalents excluded from EPS | 421,533 | | | 80,728 | | | 421,533 | | | 80,728 | |
|